Mark B Geyer

31PUBLICATIONS
145CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Child and adolescent developmentHaematologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Oct 15, 2026
Flow MRD pre-blinatumomab consolidation, despite subsequent clearance, is associated with inferior survival in Ph+ B-ALL.

|Jun 30, 2026
Zanubrutinib, obinutuzumab, and venetoclax in CLL: long-term follow up, MRD kinetics, retreatment, T-cell profiling, and PKs.

|Jun 18, 2026
Outcomes of adolescents and young adults with AML treated on pediatric vs adult protocols.

|Dec 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis.

Joseph M Rocco, Joseph H Oved, Rikita J Patel

|Dec 06, 2025
Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure.

Kuo-Kai Chin, Brian J Ball, Yasmin Abaza

|Aug 27, 2025
CD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia.

Mark B Geyer, Susan DeWolf, Xiaoli Mi

Pageof 6

Frequent Collaborators

8 joint publications

Andriy Derkach

6 joint publications

Wenbin Xiao

5 joint publications

Ahmet Dogan

4 joint publications

Jacob L Glass